The efficacy of Pomalidomide

Pomalidomide is an immunomodulator, which means it affects the activity of the immune system. Pomalidomide works in multiple ways in multiple myeloma, similar to the way other immunomodulators such as lenalidomide and thalidomide work. It also prevents the development of tumor cells by preventing the growth of blood vessels within the tumor, thereby reducing the supply of oxygen and nutrients to cancer cells. It is expected to stimulate some special cells of the immune system to attack cancer cells.

Multiple myeloma is a cancer of a type of white blood cells called plasma cells. In multiple myeloma, the plasma cells divide uncontrollably, causing abnormal, immature plasma cells to multiply and fill the bone marrow. This interferes with the production of normal white blood cells, red blood cells, and platelets, leading to complications such as anemia (low red blood cell count), bone pain and fractures, elevated blood calcium levels, and kidney disease. Pomalidomide can effectively slow the progression of the disease in patients with multiple myeloma whose disease has not improved or has relapsed after previous treatment, and its side effects are acceptable for these patients.

Pomalidomide, independently developed in China, has been launched domestically and has now entered the scope of medical insurance. The price of domestically produced Pomalidomide may be around RMB 4,000 per box, while the Turkish version sold overseas may be priced around RMB 15,000 per box (the price may fluctuate due to exchange rates), which is relatively expensive. There are also cheaper generic drugs produced in other countries overseas. The price of each box produced by a Lao pharmaceutical factory may be around a few hundred yuan (the price may fluctuate due to the exchange rate). The ingredients of foreign generic drugs, domestically produced drugs and foreign original drugs are basically the same. For more drug information and specific prices, please consult Yaode Medical Consultant.